iGEM comes of age: trends in its research output

Nat Biotechnol. 2021 Dec;39(12):1599-1601. doi: 10.1038/s41587-021-01152-7.

Ashwin K Jainarayanan^{1

2}, Anastasios Galanis^{3

4}, Athira Sreejith^{3

5}, Sourav Suresh^{3

5}, Amatullah Mustafa Nakara³, Guilherme E Kundlatsch^{3

6}, Roger Rubio-Sánchez^{7

8}

¹ Academia & Research Committee, After iGEM Team, iGEM Foundation, Cambridge, MA, USA. ashwin.jainarayanan@exeter.ox.ac.uk.
² The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. ashwin.jainarayanan@exeter.ox.ac.uk.
³ Academia & Research Committee, After iGEM Team, iGEM Foundation, Cambridge, MA, USA.
⁴ Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center "Alexander Fleming", Vari, Greece.
⁵ Department of Physical Sciences, Indian Institute of Science Education and Research, Mohali, India.
⁶ School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
⁷ Academia & Research Committee, After iGEM Team, iGEM Foundation, Cambridge, MA, USA. rmr44@cam.ac.uk.
⁸ Biological and Soft Systems, Cavendish Laboratory, University of Cambridge, Cambridge, UK. rmr44@cam.ac.uk.

No abstract available

Grants and funding